The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia

American Journal of Hematology

Volumn 82, Issue 10, 2007, Pages 906-910

  Tumer, Tugba Boyunegmez ^a   Ulusoy, Gulen ^a   Adali, Orhan ^a   Sahin, Gurses ^b   Gozdasoglu, Sevgi ^c   Arinç, Emel ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLELE; ARTICLE; CHILD; CYP1A1 GENE; CYP2E1 GENE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GSTM1 T1 GENE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; TPMT GENE; TURKEY (REPUBLIC);

6-MERCAPTOPURINE; ADOLESCENT; ALLELES; AMINO ACID SUBSTITUTION; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METABOLIC DETOXICATION, DRUG; METHYLTRANSFERASES; NEUTROPENIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PRODRUGS; RETROSPECTIVE STUDIES; TURKEY;

EID: 34848878127     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20947     Document Type: Article

References (35)

1. Chessells JM, Harrison G, Lilleyman JS, et al. Continuing (maintenance) therapy in lymphoblastic leukaemia: Lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol 1997;98:945-951.
2. Evans WE, Relling MV, Rodman JH, et al. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998;338:499-505.
3. Weinshilboum R. Thiopurine pharmacogenetics: Clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos 2001;29:601-605.
4. Spire-Vayron de la Moureyre C, Debuysere H, Mastain B, Vinner E, Marez D, Lo Guidice JM, et al. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 1998;125:879-887.
5. Lennard L, Maddocks J. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells. J Pharm Pharmacol 1983;35:15-18.
6. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-662.
7. Coulthard S, Hogarth L. The thiopurines: An update. Invest New Drugs 2005;23:523-532.
8. Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999;91:2001-2008.
9. Leeder JS. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond. Drug Discov Today 2004;9:567-573.
10. Tai HL, Krynetski EY, Schuetz EG, et al. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA 1997;94:6444-6449.
11. Szumlanski C, Otterness D, Her C, et al. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996;15:17-30.
12. Hamdan-Khalil R, Allorge D, Lo-Guidice JM, et al. In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase. Biochem Biophys Res Commun 2003;309:1005-1010.
13. Hamdan-Khalil R, Gala JL, Allorge D, et al. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*6 and TPMT*19. Biochem Pharmacol 2005;69:525-529.
14. Schaeffeler E, Eichelbaum M, Reinisch W, et al. Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - Association with decreased enzyme function. Hum Mutat 2006;27:976-983.
15. Yates CR, Krynetski EY, Loennechen T. Molecular diagnosis of thiopurine S-methyl transferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997;126:608-616.
16. Krynetski EY, Schuetz JD, Galpin AJ, et al. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA 1995;92:949-953.
17. Loennechen T, Yates CR, Fessing MY et al. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans. Clin Pharmacol Ther 1998;64:46-51.
18. McLeod HL, Coulthard S, Thomas AE, et al. Analysis of thiopurine methyl-transferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol 1999;105:696-700.
19. Hon YY, Fessing MY, Pui CH, et al. Polymorphism of the thiopurine S-methyl-transferase gene in African-Americans. Hum Mol Genet 1999;8:371-376.
20. Ameyaw MM, Collie-Duguid ES, Powrie RH, et al. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 1999;8:367-370.
21. Rossi AM, Bianchi M, Guarnieri C, et al. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 2001;57:51-54.
22. Hiratsuka M, Inoue T, Omori F, et al. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 2000;448:91-95.
23. Chang JG, Lee LS, Chen CM, et al. Molecular analysis of thiopurine S-methyl-transferase alleles in South-east Asian populations. Pharmacogenetics 2002;12:191-195.
24. Kham SK, Tan PL, Tay AH, et al. Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2002;24:353-359.
25. Larovere LE, de Kremer RD, Lambooy LH, De Abreu RA. Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem 2003;40:388-393.
26. Isaza C, Henao J, Lopez AM, Cacabelos R. Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find Exp Clin Pharmacol 2003;25:423-429.
27. Zhang JP, Guan YY, Wu JH, et al. Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: A comparison of Han and Yao ethnic groups. Br J Clin Pharmacol 2004;58:163-168.
28. Wei H, Zhou S, Li C, et al. Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks. Pharm Res 2005;22:1762-1766.
29. McLeod HL, Pritchard SC, Githang J, et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: Evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 1999;9:773-776.
30. Alves S, Rocha J, Amorim A, Prata MJ. Tracing the origin of the most common thiopurine methyltransferase (TPMT) variants: Preliminary data from the patterns of haplotypic association with two CA repeats. Ann Hum Genet 2004;68:313-323.
31. Ada AO, Süzen SH, Iscan M. Polymorphisms of cytochrome P450 1A1, gluthatione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 2004;151:311-315.
32. Aynacioglu AS, Brockmoller J, Bauer S, et al. Frequency of cytochrome P4502C9 variants in a Turkish population and functional relevance for Phenytoin. Br J Clin Pharmacol 1999;48:409-415.
33. Ulusoy G, Arinç E, Adali O. CYP2E1 genotyping in Turkish population: Determination of CYP2E17z.ast;5B, *6 and *7B alleles. Drug Metab Rev 2005;37:349.
34. Balta G, Yuksek N, Ozyurek E, et al. Characterization of MHTFR, GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes in childhood acute leukemia. Am J Hematol 2003;73:154-160.
35. 2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 1993;31:321-328.